tiprankstipranks
Livzon Pharmaceutical Group Plans Key Meeting for 2024
Company Announcements

Livzon Pharmaceutical Group Plans Key Meeting for 2024

Livzon Pharmaceutical Group (HK:1513) has released an update.

Stay Ahead of the Market:

Livzon Pharmaceutical Group Inc. has announced its 2024 third extraordinary general meeting set for November 26, aiming to approve a three-year guarantee framework agreement with its subsidiary Livzon MAB and the utilization of remaining proceeds for working capital. Additionally, the election of Lin Nanqi as a non-executive director will be considered. Investors may find interest in these strategic moves as they could impact the company’s financial dynamics and governance structure.

For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskLivzon Pharmaceutical Signs 2025 Agreements with Joincare
TipRanks HongKong Auto-Generated NewsdeskLivzon Pharmaceutical Appoints New Company Secretary
TipRanks HongKong Auto-Generated NewsdeskLivzon Pharmaceutical’s 2025 Deals with Livzon MAB Unveiled
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App